Interestingly, 3 out of 13 gliomas did not present mutations in IDH, TERT, or EGFR, and were thus classified as “Diffuse gliomas IDH-wild type NEC (Not Elsewhere Classified)” (Figure 1). This evidence concerns the gene IDH1 and central nervous system cancer.